Immunochemical study on the contribution of hypolipidaemic-induced cytochrome P-452 to the metabolism of lauric acid and arachidonic acid

This publication has 25 references indexed in Scilit:

• Multiple forms of hepatic cytochrome P-450. Purification, characterisation and comparison of a novel clofibrate-induced isozyme with other major forms of cytochrome P-450
  European Journal of Biochemistry, 1984
• Induction of cytosolic and microsomal epoxide hydrolases by the hypolipidaemic compound nafenopin in the mouse liver
  Biochemical Pharmacology, 1984
• Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans
  CRC Critical Reviews in Toxicology, 1983
• Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid)
  Biochemical Journal, 1982
• Endogenous substrates of monooxygenases: Fatty acids and prostaglandins
  Pharmacology & Therapeutics, 1980
• The proliferative response of hepatic peroxidomes of neonatal rats to treatment with SU-13 437 (nafenopin).
  The Journal of cell biology, 1977
• Three Hypolipidemic Drugs Increase Hepatic Palmitoyl-Coenzyme A Oxidation in the Rat
  Science, 1977
• Kinetic parameters of drug-metabolizing enzymes in Ca2+-sedimented microsomes from rat liver
  Biochemical Pharmacology, 1972
• RESPONSE OF HEPATIC MICROBODIES TO A HYPOLIPIDEMIC AGENT, ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB)
  The Journal of cell biology, 1966
• NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT
  Nature, 1965